Arabic Arabic English English French French German German
dark

Arrowhead Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that as an inducement to entering into employment with the Company, on July 1, 2021, the Compensation Committee of the Company’s Board of Directors approved “inducement” grants to 42 new employees under Rule 5635(c)(4) of the NASDAQ Listing Rules. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

BioIVT Opens New, Larger UK Blood Donor Center on Imperial College London’s White City Campus

Next Post

Batavia Biosciences successfully manufactures IAVI’s Lassa fever vaccine candidate on innovative HIP-Vax platform to support Phase I clinical trials

Related Posts
Total
0
Share